Scancell Hldgs Share Price (SCLP)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Scancell Hldgs	LSE:SCLP	London	Ordinary Share	GB00B63D3314	ORD 0.1P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-0.05p	-0.41%	12.05p	411,001	15:40:44
Bid Price		Offer Price	High Price	Low Price	Open Price
12.00p		12.10p	12.35p	12.05p	12.10p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	0.0	-4.5	-1.4	-	45.12

Related Shares
GlaxoSmithKline (GSK), AstraZeneca (AZN), Geiger Count. S (GCS), Port Erin (PEBI)

Scancell Hldgs (SCLP) Latest News

Scancell Hldgs News

Date	Time	Source	Headline
23/4/2018	12:43	UKREG	Scancell Holdings Plc Holding(s) in Company
20/4/2018	16:32	UKREG	Scancell Holdings Plc Holding(s) in Company
18/4/2018	15:09	ALNC	UPDATE: Scancell Raises GBP7.5 Million, Makes Antibody Acquisition (ALLISS)
18/4/2018	14:35	ALNCF	Alliance News Flash Headline
18/4/2018	14:29	UKREG	Scancell Holdings Plc Result of Placing and Subscription and PDMR
18/4/2018	11:44	ALNC	Scancell Announces GBP8 Million Fundraise, Makes Antibody Acquisition..
18/4/2018	11:05	UKREG	Scancell Holdings Plc Second Price Monitoring Extn
18/4/2018	11:00	UKREG	Scancell Holdings Plc Price Monitoring Extension
18/4/2018	07:01	RNSNON	Scancell Holdings Plc Technology acquired from University of Nottingham
18/4/2018	07:00	UKREG	Scancell Holdings Plc Proposed Placing, Subscription and Open Offer

More Scancell Hldgs News

Scancell Hldgs Takeover Rumours

Scancell Hldgs (SCLP) Share Charts

1 Year Scancell Hldgs Chart

1 Month Scancell Hldgs Chart

Intraday Scancell Hldgs Chart

Scancell Hldgs (SCLP) Discussions and Chat

Scancell Hldgs Forums and Chat

Date	Time	Title	Posts
25/4/2018	17:47	Using immunology to fight cancer.	15,407
16/10/2016	20:04	Scancell short thread	1
16/9/2016	14:20	Could this be the end of cancer?	750
22/8/2016	08:20	Question	11
16/8/2014	08:47	Using immunology to fight cancer (LTH W/O Rose Tints - Free Speech Thread)	161

Add a New Thread

Scancell Hldgs (SCLP) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
15:42:56	12.00	50,000	6,000.00	O
15:24:48	12.00	20,000	2,400.00	O
13:11:07	12.10	200	24.20	O
11:41:49	12.08	10,294	1,243.52	O
11:02:23	12.10	4,000	483.80	O

View all Scancell Hldgs trades in real-time

Scancell Hldgs (SCLP) Top Chat Posts

Date	Subject
25/4/2018 09:20	Scancell Hldgs Daily Update: Scancell Hldgs is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell Hldgs was 12.10p. Scancell Hldgs has a 4 week average price of 11.50p and a 12 week average price of 9.50p. The 1 year high share price is 19.25p while the 1 year low share price is currently 9.50p. There are currently 374,469,098 shares in issue and the average daily traded volume is 1,434,025 shares. The market capitalisation of Scancell Hldgs is £45,123,526.31. Read Full Thread Reply
21/4/2018 16:32	panama7: RH, if the science is as good as we are all being led to believe then this has been an incredibly poorly managed Company for 5 years. So many statements that haven't materialised having a detrimental effect on the share price every time they fail to deliver. The BOD have made so many statements that just don't stand up. They have stated on several occasions that Big Pharma want everything for nothing what an absolutely ridiculous statement to make in an industry that has seen 10's of Billions of USD change hands. All we as Investors get is excuses , they have shown Investors no respect whatsoever bearing in mind they have left many Investors out of pocket for 5 years and have shown absolutely no urgency to get those Investors money back and in fact have done the complete opposite by continually making statements and taking actions that undermine the share price I personally have some faith in the science but no faith in the BOD whatsoever. Read Full Thread Follow Reply
18/4/2018 15:13	tosh 123: Fragma, there is a tangible correlation between volumes and share price. If you suddenly hit the market with a few million shares, then the share price will almost certainly fall, so what I'm saying is that your notion about shorting is definitely possible, but IMHO, I doubt that you could short any sort of size without moving the market. It's the opposite of buying large size, unless its an OTC transaction, then large buys will move the market upwards. Read Full Thread Follow Reply
16/4/2018 11:52	inanaco: Poor old ONW ........ here is his £3 forecast """" IMAGINE ANY SUCH SALES WOULD BE LIMITED WITH THE RESIDUAL SALES BEING QUICKLY SNAPPED UP! ALL IN ALL I STAY RESOLUTELY BULLISH HERE, ALL THE WAY UP TO 300P/SHARE WHEN I'LL RECONSIDER. """"" SCLPHey all!19 Aug '12 Haven't seen a lot like this, tens of pages to catch up today's posts! Wow! So we think it's going north tomorrow? Sounds good to me! I think I'm lucky cos I bought my shares as a lock up and that's what they are! Very happy with the move so far and hope for a great deal more IDC. Have NO IDEA where they close tomorrow (I hate to say it) but it could conceivably be level or a bit lower! or higher I just don't know. One thing I do know is that I'll not be giving (sorry selling) my shares away at this level! I want to qualify for any new share offering (and I'd happily proprtionately subscribe for any new company) with the expertise of the existing researchers who make up the SCLP team! The only reason tere's a new company mooted is to allow the EXISTING trials to be completed and then (if appropriate) to sell off the proven product and allow others the opportunity to develop and market. as I understand it the new (unexpected discovery) will likely be a new stand alone company, hence the discussions with shareholders, as the discovery is Scancell's but needs to be segmented and ringfenced from those exisiting. So we possibly have two bites at the cherry, and nothing has changed the position re SClB1 where the share price was moving up in anticipation of news re report due between now and End October this year! I await any info from company re new discovery and existing shareholder entitlements IDC and as a result of the new unexpected potential research I WOULD THEN BE HAPPY TO COMMIT FURTHER FUNDS! Bear in mind I've ALWAYS said I had a self imposed upper limit to investment here, because of the last RNS I will probably put more in which suggests to me we will see Massive new investment over the coming days/weeks. In that situation I cannot see how the existing stock of share in issue can be anythiing but bid up with the limiter being any new issued capital from the latest RNS. Maybe that will create some limited sales of existing shares (To fund any new shares on offer to existing holders) but I IMAGINE ANY SUCH SALES WOULD BE LIMITED WITH THE RESIDUAL SALES BEING QUICKLY SNAPPED UP! ALL IN ALL I STAY RESOLUTELY BULLISH HERE, ALL THE WAY UP TO 300P/SHARE WHEN I'LL RECONSIDER. Otherwise I'm still a lockup holder! All of this is qualified by the usual DYOR and everything is IMHO. GLA and lets see in the morning! Oh if I have to guess tomorrow Mine's 73.5p but I stress GUESS!! (or maybe hope???)LOL Great Board this ATM!!! Inanaco has the last laugh ONW ... Read Full Thread Follow Reply
06/3/2018 15:01	tosh 123: Ineptico.... I stand by both of those posts... I'm really not sure what point you're trying to prove... are you going mad or something ? Scancell is all about potential, otherwise there would be no need for any further trials, or any further funding, as we would be generating revenue and paying a dividend ! Which bit of that most basic of business principle don't you get ? The market ( which is currently what determines the share price ) is well aware of THE RISKS ( as are the BOD ) hence the share price is where its at.. simple ! It is all about risk vs reward, as it is with EVERY investment... and the BOD are , by their own admission, trying to reduce the risk, and thereby, encourage an increase in the share price... Contrary to your now " proven to be totally wrong " posts that there is no risk. Read Full Thread Follow Reply
25/1/2018 14:19	fragma: ONW, What an odd post. "relentless share price predictions " serioulsy. The only relentless share price predictions are made by the relentlessly negative posters. you hardly see any share price ramping going on in this share. You're invested in VAL, why no such comments on the complete and utter unfounded uber ramps going on over there ? Read Full Thread Follow Reply
23/1/2018 21:30	tosh123: And with that one post you merely reiterate your complete and utter lack of any understanding what so ever.... You Buffoon ! Firstly Phase III trials, have not only been financed, but they have been completed... Sentiment ? I think not, its down to the FACT that IMM have done exactly what they promised they would do, and completed Phase III. Secondly, as well as completing Phase III trials ( which could not have had any major side effects otherwise the trial would have been stopped ), They have also announced that the recipients of the drug, and indeed the trial coordinators, have asked to EXTEND the treatment for another 6 months.... Sentiment ? I think not, its down to the fact that the trial has apparently been a success. The fact that over the last few years, IMM has gradually mitigated risk is exactly why the share price has risen nearly 400%, not sentiment.... Sentiment is driven by risk, the more comfortable people are that their risks are being reduced, the more the share price increases, the two are directly proportional. rHatton... Unfortunately i think you're right. I would venture that any funding will now be south of the current SP, which is clearly a real kick in the teeth for existing shareholders, especially those who continue to try and support the current levels, by buying more. There is now a real risk that shareholders will be diluted out of existence. Clearly, what we all hope for is someone with deep pockets and credibility to ride over the hillside and provide full financial support, for the next 3 years, however, bearing in mind that the " data room " has been seen by numerous candidates for funding, i think this scenario is becoming more and more unlikely. As i have said before, i will continue to hold " just in case " as if this does make it through the next few years, the potential remains meteoric, but lets not kid ourselves, this is now a longer term investment than it was perceived to be many years ago. I agree that the IP has somewhat increased with the evolution of Modi, but that has not, nor will it, be reflected in the share price until the OBVIOUS RISKS have been mitigated. All the while we have idiots ramping £6 / share, and claiming zero risk etc, he will be the laughing stock of the BB. Read Full Thread Follow Reply
23/1/2018 13:24	oldnotwise: R Hatton Actually there was an IMPLIED (not specific) "target" of having an event which would provide "cash to spend". This was (IMO) what the market latched onto and was linked with the manifold suggestions that funding was the crucial factor in the short term share price horizon. Thus the "target" I refer to was simply the market's view that there would be a CASH PROVIDING announcement between October 2017 and 10th January 2018. Since that event hasn't happened, that's why I said that I hope it's been delayed rather than not fulfilled. Anyway, you say there was no target, BUT you then state, "I believe there was hope from the board that recent developments would have given the share price a boost." That's PRECISELY the sort of "target" to which I refer.... RG set the share price up with that comment, and let's be honest, it's not the first time that's happened. IMO his statement was rather too specific, because I have sympathy for the view that says he was referring to the CRUK and BioNtech linkups.... but as you say ther's little to do now but sit and wait. ATB Read Full Thread Follow Reply
30/12/2017 14:46	drdobson1: ONW-Personally thought what a great post. I have been thinking along same lines re Inanaco.Is he a lot cleverer than I have given him credit for. Create the impression of being a long term holder but all the time is he has been trading SCLP-probably only revealed when his ego could not cope with the beating it was taking from the declining share price and he thought I have to be seen as a much better investor/trader than the ASTUTE. On the VAL board he was called a shorter and that he and C7 were part of a boiler room crew.Well I thought that a load of nonsense but perhaps he is a secret trader as you say that stock is a lot more volatile than here. Good traders are often perceived as being devious and only out for themselves and he certainly fits that bill By portraying himself as a self taught science guru he has sought to distract from his game plan which is to destroy investor sentiment and cause maximum bulletin board disharmony. He probably wants to get the SCLP share price to fall so he can buy and trade in fact he may not have much of a holding at all. He is as cunning as a cartload of monkeys and slippery as an eel and has me totally fooled or am I being too kind t9 him. Anyway all have a happy new year Read Full Thread Follow Reply
20/12/2017 10:48	rhatton: Agema what was apparent at the AGM was the need to validate the tech to raise the share price and make the company more enticing to investors. The way I see it, two ways actually, has the CRUK partnership provided that validation that a US investor was looking for? Also has the CRUK partnership increased the share price enough to minimise dilution. So in answer to the above I can’t tell regarding the first part but I’d hazardous a guess no for the second part. So maybe they wait longer to go back to the US for the cash whilst trying to pin a deal on moditope to raise the share price? That is a possibility, but again means more delays to SCIB1 trial. At least 2019 will mark SCIB2 into trails, that is certain. But also a long way away! Read Full Thread Follow Reply
23/11/2017 16:00	inanaco: ""if you make a statement that i cannot reason against then your statement becomes the lead policy which i then support "" yes because most of the intense discussion are on the science that impact IP value """There are plenty. Here's just one: share price down from 60p to 12p. Isn't that a negative? I make it negative 48p."""" That's sentiment has the science stood still in all that time, ? ""the Shareprice is not relevant as all i am trying to show is it's cheap relative to the IP.<<br /> Two fatal flaws in one sentence: 1) How on earth can you say the share price isn't relevant??!! It is very relevant if you have invested and need to sell.""" You have now added a third party ie somebody that needs to sell, that is not my position. """It is relevant to how easy it is for SCLP to raise new funds and at what price those funds are raised and therefore relevant to the amount of dilution of our investment.""" Very true, But like you have done, you can then look at the shares in issue and assess the likely outcome of capital growth based on the resultant influx of cash and how the science develops from that Dilution so has a result on both sides of the equation Ie A bigger increase in capital growth than was forecast without that expenditure. """ all i am trying to show is it's cheap relative to the IP.<<br /> Well you haven't! """ I have but maybe you have not understood the years of comparing and understanding of the science of others with wildforce allowed us to pretty well place Scancell into the market place and place reasoned value to the IP """" lozan/Tosh, Mr W cannot explain why the IP has a lower value to the share price <<br /> The IP has a lower value to the SP? Are you saying the IP is not worth 12p? """ actually the buying of the share by Loz at 47p and selling at 53p would indicate Loz buying at the level was cheap and selling at 53p produced a true value event. to then argue its only worth 12p with that evidence would be difficult ... but Loz would have to show comparative value to the IP .. being 12p .. which i suspect would be impossible """not a point worth discussing as No conclusion will be ever drawn from it as its not linked to IP only market sentiment on any particular day ...<<br /> You have a point, why worry about a share price of 12.3 when it could easily be 12.5 tomorrow."" I am not worried about the share price, i already feel the value way exceeds this level, and indeed the Board of Scancell accept that, hence they want to raise the big amounts not based on share price but IP .. however they will always have the fall back position of market priced cash raising which again is Not Ip priced cash raising like a deal """thus all the posts can be dismissed as not relevant, <<br /> In YOUR opinion, which here does not command a very high level of respect"""" then show me posts that you feel are of High Value that i have missed, like i said I debate for my own investment position ..I defend Scancell because I am invested not because your invested, Read Full Thread Follow Reply

Scancell Hldgs share price data is direct from the London Stock Exchange

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:42 V: D:20180425 20:31:00